Peter Wirth

Companies

• Zai Lab LimitedBoard member Jan 4, 2021 to now¹
• Syros Pharmaceuticals, Inc.Board member Jan 30, 2017 to Jun 7, 2024²
• Forma Therapeutics Holdings, Inc.Board member Jun 18, 2020 to Oct 14, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ZLZai Lab Limited ZLAB416,121 shares⁴$9.9M at $23.71Jun 17, 2026
• FTForma Therapeutics Holdings, Inc.0 shares⁵Oct 14, 2022
• SPSyros Pharmaceuticals, Inc.16,000 shares⁶Jun 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 17, 2026Granted 22,371 shares of Zai Lab Limited⁴
• Jun 18, 2025Granted 10,831 shares of Zai Lab Limited⁷
• Jun 18, 2024Granted 21,253 shares of Zai Lab Limited⁸
• Jun 5, 2024Granted 4,000 shares of Syros Pharmaceuticals, Inc.⁶
• Jun 29, 2023Granted 18,903 shares at $26.45 of Zai Lab Limited⁹
• Jun 1, 2023Granted 4,000 shares of Syros Pharmaceuticals, Inc.¹⁰
• Dec 8, 2022Sold 4,000 shares at $35.33 of Zai Lab Limited¹¹
• Dec 8, 2022Sold 3,852 shares at $35.37 of Zai Lab Limited¹¹
• Oct 14, 2022U 7,250 shares of Forma Therapeutics Holdings, Inc.⁵
• Oct 14, 2022U 127,665 shares of Forma Therapeutics Holdings, Inc.⁵
• Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.¹²
• Jun 8, 2022Granted 4,500 shares of Forma Therapeutics Holdings, Inc.¹³
• Jan 3, 2022Granted 7,763 shares of Zai Lab Limited¹⁴
• Dec 8, 2021Bought 4,000 shares at $71.36 of Zai Lab Limited¹⁵
• Dec 8, 2021Bought 4,000 shares at $71.36 of Zai Lab Limited¹⁶